Singapore Biomedical R&D Consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: International Enterprise, Singapore
  • Initiator Type: Government
  • No disease focus
  • Location: Asia

Abstract

Mission

The Singapore Biomedical R&D Consortium provides standalone services based on client needs. Contract research organizations and research institutes in the island state have the technical expertise and competencies to address the needs of global biomedical companies.

The consortium aggregates key capabilities of the companies along the biomedical research and development value chain to provide a one-stop solution for global players. This equips them with the competitive edge to gain a foothold overseas.

Consortium History

June 2011: Consortium announced.

Sponsors & Partners

Dx Assays Pte Ltd.

Experimental Therapeutics Centre (ETC.)

Innoheart Pte Ltd.

Maccine Ptd Ltd.

MerLion Pharmaceuticals Pte Ltd.

PWG Genetics Pte Ltd.

Singapore Clinical Research Institute


Last Updated: 04/08/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.